Novel therapeutic approach: Organic arsenical (melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo
K. Koshiuka, E. Elstner, E. Williamson, J. W. Said, Y. Tada, H. P. Koeffler
Fingerprint
Dive into the research topics of 'Novel therapeutic approach: Organic arsenical (melarsoprol) alone or with all-trans-retinoic acid markedly inhibit growth of human breast and prostate cancer cells in vitro and in vivo'. Together they form a unique fingerprint.